Matinas BioPharma (MTNB) Stock: Buy, Sell, or Hold?
MTNB - Matinas BioPharma Holdings, Inc.
$1.91
0.08 (4.37%)
▲
5d:
+25.66%
30d:
-33.68%
90d:
+501.76%
HOLD
LOW Confidence
Analysis Updated: Oct 28, 2026 12:00 AM ET
Earnings: Nov 09, 2026
10d
Get Alerted When MTNB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MTNB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MTNB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MTNB is currently trading at $1.91, which is considered fair relative to its 30-day fair value range of $1.01 to $2.88.
Technical Outlook: Technically, MTNB is in a uptrend. Immediate support is located at $1.47, while resistance sits at $2.54. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: MTNB scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1470.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MTNB is in a uptrend. Immediate support is located at $1.47, while resistance sits at $2.54. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: MTNB scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1470.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.01 -
$2.88
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 1470.7% below Wall St target ($30.00)
- CAUTION: Bottoming setup, but lagging the sector by 18% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.01 -
$2.88
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.47
Resistance Level
$2.54
Current Trend
Uptrend
Technical data as of
Oct 28, 2026
Fundamental Context
Wall Street Target
$30.00
(+1470.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 28, 2026 8:48 PM ET
Data refreshes hourly during market hours. Next update: 9:48 PM
Data refreshes hourly during market hours. Next update: 9:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTNB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 67 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$280 | 51 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 46 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 57 HOLD |
